Most hiv drug access related news are at:

rdmag.com – Research & Development | Technologies & Strategies That Enable Research & Development

Miss. nuclear waste plan sparks early opposition 27 Aug 2013 | 06:19 am

The Mississippi Energy Institute is pushing for more exploration of storing and reprocessing used nuclear fuel in the state at the same time that one of the its congressmen is coming out against it. ...

Researchers use graphene to develop ultra-strong nanocomposite 26 Aug 2013 | 09:18 pm

A new nanocomposite material has been developed exhibiting hundreds of times greater strength than pure metals. Professor Seung Min Han and Yoo Sung Jeong (Graduate School of Energy, Environment, Wate...

More hiv drug access related news:

Early HIV Drug Therapy Protects Sex Partners From Virus aids.org 15 May 2011 | 12:54 pm

By Steven Reinberg HealthDay Reporter THURSDAY, May 12 (HealthDay News) — People with HIV can reduce the risk of infecting their sex partners by more than 90 percent if they start treatment with ant...

New Kind of Antiretroviral, KP-1461; Clinical Trial Recruiting. Interview with Stephen Becker, M.D. aids.org 21 Oct 2007 | 11:53 am

by John S. James Summary: KP-1461, an experimental HIV drug already in a phase II trial, works so differently from other antiretrovirals that at first glance it looked like science fiction, and we fo...

Gilead and 3 Indian firms partner on generics of HIV drug Emtriva stabvida.com 6 Aug 2012 | 09:18 pm

Gilead Sciences is collaborating with Strides Arcolab, Ranbaxy Laboratories and Mylan's Indian arm to increase sales and cut  -More- 

Neutron study aims to improve HIV drugs physicsworld.com 21 Aug 2013 | 06:55 pm

Hydrogen-bonding sites, pinpointed by neutron crystallography, could improve antiretrovirals

FDA Approves GlaxoSmithKline's New HIV Drug, Tivicay aids.about.com 13 Aug 2013 | 04:34 pm

GlaxoSmithKline's long-awaited integrase inhibitor-class drug, Ticivay (dolutegravir), received approval on Monday from the U.S. Food and Drug Administration. The once-daily HIV treatment is the third...

HIV Researchers have Cautious Breakthrough with Bone Marrow ck-it.co.uk 4 Jul 2013 | 02:30 pm

The BBC has reported that two men have been taken off HIV drugs after bone marrow transplants seemed to remove the virus from their systems. The men, who both developed lymphoma and as such needed a ...

Anti-HIV drugs can reduce the occurrence of leukemia patients after bone marrow transplantation risk of dangerous complications pinktac.com 8 Jul 2013 | 08:23 am

Published within the "New European country Journal of Medicine", a brand new study reveals: University of Pennsylvania researchers have confirmed Associate in Nursing anti-HIV medicine will cut back t...

Will You Have Access to Those Drugs That Work After a Trial Is Complete? 4therapy.com 28 Jul 2000 | 07:00 pm

Blurb: Often, the company developing a new drug may try to see that you can continue to get it, even before the FDA has approved it for sale. You may be able to do this under what is termed a compas....

Longer breastfeeding cuts HIV transmission to babies healthynewsblogs.wordpress.com 26 Apr 2012 | 10:01 pm

Scientists had revealed that giving daily antiretroviral drugs (ART) to HIV-infected moms or their breastfeeding babies for 28 weeks proved safe and effective for preventing mother-to-child HIV transm...

Activists Advise Caution About Access Program acria.org 10 Feb 2012 | 10:34 am

Activists Caution HIV+ Patients and their Physicians About Monotherapy in Upcoming Access Program read more

Recently parsed news:

Recent keywords:

Recent searches: